Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

MicroRNA-139 Inhibits Hepatocellular Carcinoma Cell Growth Through Down-Regulating Karyopherin Alpha 2

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

Microrna-139 Suppresses Proliferation of Hepatocellular Carcinoma Cells by Silencing of B Cell Translocation Gene 3

MicroRNA-145 Suppresses Hepatocellular Carcinoma by Targeting IRS1 and Its Downstream Akt Signaling.

MicroRNA-139 Suppresses Hepatocellular Carcinoma Cell Proliferation and Migration by Directly Targeting Topoisomerase I.

MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma

Mir-139 Regulates the Proliferation and Invasion of Hepatocellular Carcinoma Through the WNT/TCF-4 Pathway.

MicroRNA-181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG

Microrna-134 Inhibits Hcc Cell Growth And Migration Through The Akt/Gsk3 Beta/Snail Signaling Pathway

MicroRNA-197-3p Acts As a Prognostic Marker and Inhibits Cell Invasion in Hepatocellular Carcinoma

Downregulation of Mir-136-5p in Hepatocellular Carcinoma and Its Clinicopathological Significance

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.

MicroRNA‑9‑5p Downregulates Klf4 and Influences the Progression of Hepatocellular Carcinoma Via the AKT Signaling Pathway.

MicroRNA-381 Suppresses Cell Growth and Invasion by Targeting the Liver Receptor Homolog-1 in Hepatocellular Carcinoma.

miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2

MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1

Microrna-141 Inhibits Cell Proliferation and Invasion and Promotes Apoptosis by Targeting Hepatocyte Nuclear Factor-3Β in Hepatocellular Carcinoma Cells

MicroRNA-1405 p suppresses tumor growth and metastasis by targeting TGFBR 1 and FGF 9 in Hepatocellular carcinoma

MicroRNA-138 Targets SP1 to Inhibit the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells

MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways